Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-939|1|4167|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional Carcinoma, Urinary Bladder Urinary Bladder Tumor,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-949|1|4921|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-978|1|6172|Intervertebral disk syndrome,|Cervical vertebra,|/ Herniated Vertebral Disc Cervical Disc Disease,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-990|1|2965|Pyometra,|Uterus,|/ Pyometra,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-996|1|4785|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1005|1|5748|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1007|1|6145|Nephropathy, chronic,|Kidney,|/ Chronic Nephropathy Chronic Nephropathy,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1024|1|5872|Transitional cell carcinoma, malignant,|Urethra,|/ Transitional Carcinoma, Urethra Trans. Cell Carc. Urethra,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1038|1|5598|Hemangiosarcoma (Angiosarcoma), malignant,|Spleen,|/ Hemangiosarcoma, Spleen Hemangiosarcoma, Spleen,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1045|1|5406|Hemangiosarcoma (Angiosarcoma), malignant,Amyloidosis,|Spleen,Kidney,|,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1054|1|6310|Glomerulosclerosis,|Kidney,|/ Chronic Nephropathy Chronic Nephropathy,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1061|1|3599|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1093|1|4335|Adenoma, pituitary, with hydrocephalus,Hyperadrenocorticism (Cushings's Disease),|Pituitary gland,Adrenal gland,|,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1097|1|6092|Transitional cell carcinoma, malignant,|Nasal cavity,|/ Nasal Transitional Carcinoma Nasal Transitional Carcinoma,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1112|1|5431|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1116|1|6280|Hemangiosarcoma (Angiosarcoma), malignant,|Omentum (Abdominal Fat),|/ Hemangiosarcoma, Omentum Hemangiosarcoma, Omentum,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1186|1|4727|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional Carcinoma, Urinary Bladder Urinary Bladder Tumor,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1197|1|6081|Inflammation, pneumonia, septic,|Lung,|/ Pneumonia,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1209|1|5953|Inflammation with fibrosis,|Lung,|/ Pulmonary Interstial Fibrosis Pulmonary Interstial Fibrosis,|
1004-4-1|Control,CONTROL 0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|life span control|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-1-1225|1|5484|Adenoma, pituitary, with hydrocephalus,|Pituitary gland,|/ Adenoma, Pituitary Pituitary Adenoma,|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-966|2|2178|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1011|2|2554|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1013|2|2916|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1087|2|1826|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1118|2|1447|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1223|2|971|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1227|2|1519|n/a|n/a|n/a|
1004-4-2|Controls Sacrificed at 3 to 8 years old,CONTROL-SAC0 kBq/kg|1|400|none (controls)|0|unit code not relevant|not applicable or not supplied|dosimetry control sacrifice|8 (8 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-2-1228|2|2218|n/a|n/a|n/a|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-951|3|4297|Death, anesthetic,|Topography, multiple sites,|/ Anesthetic Death Anesthetic Death,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-959|3|4788|Abscess,|Liver,|/ Liver Abscess,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-989|3|3571|Neoplastic disease, uncertain whether benign or malignant,Fibrosarcoma, malignant,|Skeletal bone,|,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-993|3|5515|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-998|3|5429|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1003|3|5784|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional Carcinoma, Urinary Bladder Transitional Carc, Uri Bladr,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1008|3|5258|Fibrosarcoma, malignant,|Spleen,|/ Fibrosarcoma, Spleen Fibrosarcoma, Spleen,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1023|3|6130|Inflammation, pneumonia, septic,|Lung,|/ Pneumonia,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1039|3|5433|Heart failure, (Congestive),|Heart,|/ Heart Failure,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1044|3|6221|Seizure syndrome,|Brain,|/ Epileptic Seizures,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1055|3|5760|Melanoma, malignant,|Oral cavity,|/ Malignant Melanoma, Oral Cavity Malignant Melanoma, Oral,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1063|3|3361|Neoplasm, uncertain whether benign or malignant,Neoplastic disease, uncertain whether benign or malignant,|Brain,Heart,|,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1069|3|4228|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1095|3|5692|Glomerulosclerosis,|Kidney,|Chronic Nephropathy / Chronic Nephropathy Chronic Nephropathy,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1105|3|4769|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1106|3|4072|Carcinoma, malignant,Neoplasm, uncertain whether benign or malignant,Osteoarthropathy, hypertrophic,|Adrenal gland,Adrenal gland,Humerus,|,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1193|3|4899|Anemia,|Hemolysis, increased,|Immune Hemolytic Anemia / Immune Hemolytic Anemia Immune Hemolytic Anemia,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1194|3|4849|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1204|3|6015|Transitional cell carcinoma, malignant,|Urethra,|/ Transitional Carcinoma, Urethra Trans. Cell Carc, Urethra,|
1004-4-3|0.0002 uCi/kg Initial Body Burden,LOWEST 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-3-1230|3|5109|Hemangiosarcoma (Angiosarcoma), malignant,|Liver,|/ Hemangiosarcoma, Liver Hemangiosarcoma, Liver,|
1004-4-4|0.0002 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|5 (5 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-4-921|4|622|n/a|n/a|n/a|
1004-4-4|0.0002 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|5 (5 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-4-923|4|652|n/a|n/a|n/a|
1004-4-4|0.0002 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|5 (5 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-4-925|4|684|n/a|n/a|n/a|
1004-4-4|0.0002 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|5 (5 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-4-970|4|2061|n/a|n/a|n/a|
1004-4-4|0.0002 uCi/kg Initial Body Burden, SACRIFICED,LOWEST-SAC 0.13 kBq/kg|1|400|Pu-238 dioxide|0.0002|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|5 (5 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-4-1215|4|1690|n/a|n/a|n/a|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-955|5|5737|Neoplasm, uncertain whether benign or malignant,Bile duct adenoma, benign,|Lung,Biliary tract,|,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-971|5|4372|Hemangiosarcoma (Angiosarcoma), malignant,|Spleen,|/ Hemangiosarcoma, Spleen Hemangiosarcoma, Spleen,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-981|5|6447|Glomerulosclerosis,|Kidney,|/ Chronic Nephropathy Chronic Nephropathy,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-999|5|5359|Sarcoma, malignant,Neoplasm, uncertain whether benign or malignant,|Nasal cavity,Lung,|,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1033|5|5261|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1036|5|5739|Melanoma, malignant,|Oral cavity,|/ Malignant Melanoma, Oral Cavity Malignant Melanoma, Oral,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1046|5|5961|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1050|5|5379|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1060|5|4862|Inflammation, pneumonia, septic,|Lung,|/ Pneumonia,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1065|5|5255|Lymphoma, malignant,Neoplasm, uncertain whether benign or malignant,|Topography, multiple sites,Lung,|,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1070|5|4400|Lymphoma, malignant,Sarcoma, malignant,|Topography, multiple sites,Kidney,|,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1078|5|4363|Meningioma, malignant,|Brain,|/ Malignant Meningioma Meningioma, Malignant,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1082|5|2927|Paralysis,|Spinal cord,|/ Paralysis, Spinal Cord Degeneration Paralysis, Spinal Cord Degen. /,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1084|5|6457|Lymphoma, malignant,|Heart,|/ Malignant Lymphoma, Heart Malignant Lymphoma, Heart,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1090|5|5618|Heart failure, (Congestive),|Heart,|/ Heart Failure,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1188|5|4169|Neoplasm, malignant, w/evidence of metastasis,|Lung,|/ Metastatic Lung Tumor, Primary Site Unknown Metastatic Lng Tmr, Prim. Unk.,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1196|5|5961|Carcinoma, malignant,Neoplasm, uncertain whether benign or malignant,|Salivary gland,Lung,|,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1207|5|5815|Intervertebral disk syndrome,|Vertebra,|/ Herniated Vertebral Disc Herniated Vert Disc,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1216|5|5338|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1222|5|4932|Mesothelioma, uncertain whether benign or malignant,|Mediastinum,|/ Malignant Mesothelioma Malign (mediast) Mesothelioma,|
1004-4-5|0.0016 uCi/kg Initial Body Burden,LOW 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|21 (21 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-5-1229|5|4251|Carcinoma, malignant,Inflammation, pneumonia, septic,|Thyroid gland,Lung,|,|
1004-4-6|0.0016 uCi/kg Initial Body Burden, SACRIFICED,LOW-SAC 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|3 (3 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-6-930|6|611|n/a|n/a|n/a|
1004-4-6|0.0016 uCi/kg Initial Body Burden, SACRIFICED,LOW-SAC 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|3 (3 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-6-1189|6|2443|n/a|n/a|n/a|
1004-4-6|0.0016 uCi/kg Initial Body Burden, SACRIFICED,LOW-SAC 0.68 kBq/kg|1|400|Pu-238 dioxide|0.0016|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|3 (3 in ERA)|Dog|Dog, Beagle|Male|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-6-1214|6|975|n/a|n/a|n/a|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-960|7|3465|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-972|7|5407|Allergic pneumonitis,|Lung,|/ Allergic Bronchitis Allergic Bronchitis,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-982|7|5368|Carcinoma, malignant,Inflammation, pneumonia, septic,|Thyroid gland,Lung,|,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1000|7|6029|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional Carcinoma, Urinary Bladder Transitional Carc, Uri Bladr,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1004|7|5813|Lymphoma, malignant,Sarcoma, malignant,Neoplasm, uncertain whether benign or malignant,|Topography, multiple sites,Liver and gallbladder,Lung,|,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1026|7|5265|Dysplasia,|Liver,|/ Hepatic Dysplasia Hepatic Displasia,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1031|7|4669|Inflammation, pneumonia, septic,|Lung,|/ Pneumonia,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1040|7|3485|Heart failure, (Congestive),Adenoma, benign,|Heart,Parathyroid gland,|,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1043|7|3685|Neoplasm, uncertain whether benign or malignant,Inflamation, acute exudative (suppurative),|Pituitary gland,Pleura,|/ Empyema; Adenoma, Pituitary; Cushing's Disease Empyema, Pituit.T., Cushing's / ,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1056|7|5408|Carcinoma, malignant,Inflammation, pneumonia, septic,|Thyroid gland,Lung,|,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1059|7|4361|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1066|7|4231|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1072|7|4318|Inflammation, pneumonitis, radiation induced,|Lung,|Delayed / Radiation Pneumonitis, Delayed Delayed Radiation Pneumonitis,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1089|7|6087|Glomerulosclerosis,|Kidney,|/ Chronic Nephropathy Chronic Nephropathy,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1108|7|5474|Paralysis,|Posterior midline of trunk,|/ Posterior Paralysis Posterior Paralysis,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1158|7|5876|Carcinoma, malignant,|Nasal cavity,|/ Nasal Carcinoma Nasal Carcinoma,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1165|7|5168|Inflammation, pneumonia, septic,|Lung,|/ Pneumonia,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1190|7|4641|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1219|7|5193|Glomerulosclerosis,|Kidney,|Chronic Nephropathy / Chronic Nephropathy Chronic Nephropathy,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1221|7|5858|Lymphoma, malignant,Sarcoma, malignant,|Topography, multiple sites,Liver and gallbladder,|,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1309|7|4995|Hemangiosarcoma (Angiosarcoma), malignant,|Liver,|/ Hemangiosarcoma, Liver Hemangiosarcoma, Liver,|
1004-4-7|0.007 uCi/kg Initial Body Burden,MED-LOW 3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|22 (22 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-7-1316|7|5585|Ankylosing spondylitis,Paralysis,|Skeletal system,Posterior midline of trunk,|,|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-926|8|685|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-929|8|639|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1310|8|1322|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1311|8|1689|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1312|8|2046|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1315|8|1310|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1317|8|1311|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1318|8|922|n/a|n/a|n/a|
1004-4-8|0.007 uCi/kg Initial Body Burden, SACRIFICED,MED-LOW-SAC  3.1 kBq/kg|1|400|Pu-238 dioxide|0.007|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|9 (9 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-8-1319|8|923|n/a|n/a|n/a|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-952|9|4403|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-973|9|4895|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-983|9|4606|Carcinoma, malignant,Neoplasm, uncertain whether benign or malignant,|Adrenal gland,Pituitary gland,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-991|9|4408|Transitional cell carcinoma, malignant,|Urinary bladder transitional epithelium,|/ Transitional Carcinoma, Urinary Bladder Urinary Bladder & Ovarian Tmr,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-997|9|5456|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1030|9|4283|Inflammation, pneumonitis, radiation induced,|Lung,|/ Pneumonia; Radiation Pneumonitis Pneumonia, Rad. Pneumonitis / ,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1053|9|4908|Hyperadrenocorticism (Cushings's Disease),|Adrenal gland,|/ Cushing's Disease Cushing's Disease,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1062|9|4657|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1081|9|2972|Hemangiosarcoma (Angiosarcoma), malignant,|Heart,|/ Hemangiosarcoma, Heart Hemangiosarcoma, Heart,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1091|9|5437|Carcinoma, malignant,|Thyroid gland,|/ Carcinoma, Thyroid Thyroid Carcinoma,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1103|9|4102|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1114|9|4843|Neoplastic disease, uncertain whether benign or malignant,Carcinoma, malignant,|Skeletal bone,Biliary tract,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1166|9|4410|Lymphoma, malignant,|Topography, multiple sites,|/ Malignant Lymphoma Malignant Lymphoma,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1176|9|4923|Hemangiosarcoma (Angiosarcoma), malignant,|Spleen,|/ Hemangioma, Spleen Hemangioma, Spleen,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1177|9|4648|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1191|9|1670|Inflammation, diffuse, interstitial,|Lung,|/ Interstitial Pneumonitis Interstitial Pneumonitis,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1195|9|5452|Glomerulosclerosis,Bile duct adenoma, benign,|Kidney,Biliary tract,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1198|9|5127|Carcinoma, malignant,Inflammation, pneumonia, septic,|Lung,Lung,|,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1212|9|5767|Hepatocellular carcinoma, malignant,|Liver,|/ Hepatocellular Carcinoma Hepatocellular Carcinoma,|
1004-4-9|0.029 uCi/kg Initial Body Burden,MEDIUM  13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-9-1220|9|5197|Lymphoma, malignant,Adrenocortical insufficiency syndrome, chronic (Addison's di,|Topography, multiple sites,Adrenal gland,|,|
1004-4-10|0.029 uCi/kg Initial Body Burden,MEDIUM-SAC 13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-10-931|10|610|n/a|n/a|n/a|
1004-4-10|0.029 uCi/kg Initial Body Burden,MEDIUM-SAC 13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-10-932|10|638|n/a|n/a|n/a|
1004-4-10|0.029 uCi/kg Initial Body Burden,MEDIUM-SAC 13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-10-934|10|673|n/a|n/a|n/a|
1004-4-10|0.029 uCi/kg Initial Body Burden,MEDIUM-SAC 13 kBq/kg|1|400|Pu-238 dioxide|0.029|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|4 (4 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-10-1032|10|504|n/a|n/a|n/a|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-974|11|2566|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-992|11|4810|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1027|11|2726|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1035|11|4581|Neoplastic disease, uncertain whether benign or malignant,Hyperadrenocorticism (Cushings's Disease),|Skeletal bone,Adrenal gland,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1047|11|4064|Intervertebral disk syndrome,|Vertebra,|/ Herniated Vertebral Disc Vertebral Disk Herniation,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1058|11|2985|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Adrenal gland,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1071|11|3332|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1079|11|2267|Neoplastic disease, uncertain whether benign or malignant,Adrenocortical insufficiency syndrome, chronic (Addison's di,|Gastrointestinal tract,Adrenal gland,|/ Addison's Disease Addison's Disease, G.I. Tumor / ,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1092|11|2497|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1096|11|2309|Adrenocortical insufficiency syndrome, chronic (Addison's di,|Adrenal gland,|/ Addison's Disease Addison's Disease,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1109|11|3122|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,Adrenocortical insufficiency syndrome, chronic (Addison's di,|Skeletal bone,Lung,Adrenal gland,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1115|11|2357|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1140|11|3514|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1157|11|4309|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1160|11|3405|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1173|11|3545|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1178|11|3852|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1192|11|3869|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1211|11|3537|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-11|0.11 uCi/kg Initial Body Burden,MED-HIGH 52 kBq/kg|1|400|Pu-238 dioxide|0.11|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|20 (20 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-11-1218|11|3142|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-975|12|2628|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-994|12|1861|Adrenocortical insufficiency syndrome, chronic (Addison's di,|Adrenal gland,|/ Addison's Disease Addison's Disease,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1002|12|3157|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1006|12|2787|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1009|12|2495|Neoplasm, uncertain whether benign or malignant,Osteoarthropathy, hypertrophic,|Lung,Humerus,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1025|12|2102|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1037|12|2651|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1042|12|2639|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1057|12|2749|Neoplastic disease, uncertain whether benign or malignant,|Skeletal bone,|/ Bone Tumor,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1064|12|2054|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1143|12|2044|Neoplastic disease, uncertain whether benign or malignant,Neoplasm, uncertain whether benign or malignant,|Skeletal bone,Lung,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1162|12|2397|Neoplastic disease, uncertain whether benign or malignant,Adrenocortical insufficiency syndrome, chronic (Addison's di,|Skeletal bone,Adrenal gland,|,|
1004-4-12|0.47 uCi/kg Initial Body Burden,HIGH 210 kBq/kg|1|400|Pu-238 dioxide|0.47|microcuries per kilogram animal|Inhalation|Single, nose only, exposure to aerosol|13 (13 in ERA)|Dog|Dog, Beagle|Both|need def 11|Survival, lung morphology, neoplastic changes.|1004-4-12-1175|12|2075|Neoplasm, uncertain whether benign or malignant,|Lung,|/ Lung Tumor,|
1004-4-99|Ancillary animals sacrificed for dosimetry,DOSE SACRIFICE|n/a|n/a|n/a||n/a|n/a|n/a|10 (0 in ERA)|Dog|Dog, Beagle|Both|need def 11|none|No information on individuals available for this study
